{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T02:23:20Z","timestamp":1784255000029,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.jpeds.2016.09.008","type":"journal-article","created":{"date-parts":[[2016,10,15]],"date-time":"2016-10-15T05:07:49Z","timestamp":1476508069000},"page":"241-246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Chemical Leukoderma Associated with Methylphenidate Transdermal System: Data From the US Food and Drug Administration Adverse Event Reporting System"],"prefix":"10.1016","volume":"180","author":[{"given":"Carmen","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois","family":"La Grenade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9468-5324","authenticated-orcid":false,"given":"Ida-Lina","family":"Diak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Brinker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2016.09.008_bib0010","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/jama.1939.72800350003010a","article-title":"Occupational leukoderma","volume":"113","author":"Oliver","year":"1939","journal-title":"JAMA"},{"key":"10.1016\/j.jpeds.2016.09.008_bib0015","first-page":"115","article-title":"Occupational vitiligo due to paratertiary butylphenol and homologues","volume":"57","author":"Malten","year":"1971","journal-title":"Trans St Johns Hosp Dermatol Soc"},{"key":"10.1016\/j.jpeds.2016.09.008_bib0020","first-page":"105","article-title":"Two cases of occupational leucoderma following contact with hydroquinone monomethyl ether","volume":"29","author":"Chivers","year":"1972","journal-title":"Br J Ind Med"},{"key":"10.1016\/j.jpeds.2016.09.008_bib0025","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1034\/j.1600-0536.2002.470210_9.x","article-title":"Contact leukoderma secondary to occupational toluenediamine sulfate exposure","volume":"47","author":"Mahendran","year":"2002","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jpeds.2016.09.008_bib0030","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.0105-1873.2003.0128j.x","article-title":"Stethoscope earpiece-induced chemical depigmentation","volume":"49","author":"Srinivas","year":"2003","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jpeds.2016.09.008_bib0035","first-page":"385","article-title":"The less common occupational dermatoses","volume":"7","author":"Hogan","year":"1992","journal-title":"Occup Med"},{"key":"10.1016\/j.jpeds.2016.09.008_bib0040","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2133.2008.08815.x","article-title":"Chemical leucoderma: a clinico-aetiological study of 864 cases in the perspective of a developing country","volume":"160","author":"Ghosh","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jpeds.2016.09.008_bib0045","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4103\/0019-5154.70680","article-title":"Chemical leukoderma: what's new on etiopathological and clinical aspects?","volume":"55","author":"Ghosh","year":"2010","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.jpeds.2016.09.008_bib0050","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5070\/D36NC1W0NK","article-title":"Chemical leukoderma","volume":"17","author":"O'Reilly","year":"2011","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jpeds.2016.09.008_bib0055","series-title":"Daytrana","year":"2015"},{"key":"10.1016\/j.jpeds.2016.09.008_bib0060","series-title":"FDA adverse event reporting system (FAERS)","author":"U.S. Food and Drug Administration","year":"2016"},{"key":"10.1016\/j.jpeds.2016.09.008_bib0065","author":"Maintenance and Support Services Organization"},{"key":"10.1016\/j.jpeds.2016.09.008_bib0070","series-title":"Pigmentary disorders: a comprehensive compendium","first-page":"66","article-title":"Chemical, occupational and drug-induced pigmentary disorders","author":"Ghosh","year":"2014"},{"key":"10.1016\/j.jpeds.2016.09.008_bib0075","series-title":"UpToDate","article-title":"Vitiligo","author":"Goldstein","year":"2014"},{"key":"10.1016\/j.jpeds.2016.09.008_bib0080","series-title":"Merck manual of diagnosis and therapy","year":"2011"},{"key":"10.1016\/j.jpeds.2016.09.008_bib0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jdermsci.2015.10.011","article-title":"Rhododenol-induced leukoderma in a mouse model mimicking Japanese skin","volume":"81","author":"Abe","year":"2016","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jpeds.2016.09.008_bib0090","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/DER.0000000000000167","article-title":"Chemical leukoderma","volume":"27","author":"Bonamonte","year":"2016","journal-title":"Dermatitis"},{"key":"10.1016\/j.jpeds.2016.09.008_bib0095","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1016\/j.jaad.2011.03.030","article-title":"Chemical leukoderma after the application of a transdermal methylphenidate patch","volume":"66","author":"Ghasri","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jpeds.2016.09.008_bib0100","first-page":"46","article-title":"Contact leukoderma caused by buspirone patches","volume":"13","author":"Chapman","year":"2002","journal-title":"Am J Contact Dermat"},{"key":"10.1016\/j.jpeds.2016.09.008_bib0105","first-page":"34","article-title":"Chemical leukoderma associated with vicks VapoRub","volume":"1","author":"Boyse","year":"2008","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jpeds.2016.09.008_bib0110","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1001\/archinte.1995.00430190125021","article-title":"Skin depigmentation related to transdermal clonidine therapy","volume":"155","author":"Doe","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jpeds.2016.09.008_bib0115","series-title":"Catapres-TTS","year":"2011"},{"key":"10.1016\/j.jpeds.2016.09.008_bib0120","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0190-9622(90)70113-V","article-title":"Adverse dermatologic reactions to transdermal drug delivery systems","volume":"22","author":"Hogan","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jpeds.2016.09.008_bib0125","series-title":"Minivelle","year":"2014"},{"key":"10.1016\/j.jpeds.2016.09.008_bib0130","series-title":"CombiPatch","year":"2015"},{"key":"10.1016\/j.jpeds.2016.09.008_bib0135","series-title":"FDA Drug Safety Communication: FDA reporting permanent skin color changes associated with use of Daytrana patch (methylphenidate transdermal system) for treating ADHD","author":"U.S. Food and Drug Administration","year":"2015-2016"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347616309180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347616309180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T12:11:05Z","timestamp":1657455065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347616309180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":26,"alternative-id":["S0022347616309180"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2016.09.008","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemical Leukoderma Associated with Methylphenidate Transdermal System: Data From the US Food and Drug Administration Adverse Event Reporting System","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2016.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}